Global AAV Vector-Based Gene Therapy Drugs Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
AAV vector-based gene therapy drugs are a class of therapeutic agents used in the treatment of genetic disorders and certain diseases These drugs utilize AAV vectors, which are small, non-enveloped viruses that have a low pathogenic profile and are capable of delivering genetic material into host cells. The genetic material, which be a functional gene or a therapeutic gene, is inserted into the AAV vector and then introduced into the patient's cells, where it is intended to correct genetic mutations or produce therapeutic proteins. AAV vector-based gene therapy has shown promising results in clinical trials for conditions such as Leber congenital amaurosis, spinal muscular atrophy, and certain retinal diseases.
The global AAV Vector-Based Gene Therapy Drugs market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (LP Information)' newest research report, the “AAV Vector-Based Gene Therapy Drugs Industry Forecast” looks at past sales and reviews total world AAV Vector-Based Gene Therapy Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected AAV Vector-Based Gene Therapy Drugs sales for 2023 through 2029. With AAV Vector-Based Gene Therapy Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world AAV Vector-Based Gene Therapy Drugs industry.
This Insight Report provides a comprehensive analysis of the global AAV Vector-Based Gene Therapy Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on AAV Vector-Based Gene Therapy Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global AAV Vector-Based Gene Therapy Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for AAV Vector-Based Gene Therapy Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global AAV Vector-Based Gene Therapy Drugs.
United States market for AAV Vector-Based Gene Therapy Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for AAV Vector-Based Gene Therapy Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for AAV Vector-Based Gene Therapy Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key AAV Vector-Based Gene Therapy Drugs players cover uniQure, Spark Therapeutics, AveXis (Novartis), PTC Therapeutics, BioMarin, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of AAV Vector-Based Gene Therapy Drugs market by product type, application, key players and key regions and countries.
Segmentation by Type:
AAV vector-based gene therapy drugs are a class of therapeutic agents used in the treatment of genetic disorders and certain diseases These drugs utilize AAV vectors, which are small, non-enveloped viruses that have a low pathogenic profile and are capable of delivering genetic material into host cells. The genetic material, which be a functional gene or a therapeutic gene, is inserted into the AAV vector and then introduced into the patient's cells, where it is intended to correct genetic mutations or produce therapeutic proteins. AAV vector-based gene therapy has shown promising results in clinical trials for conditions such as Leber congenital amaurosis, spinal muscular atrophy, and certain retinal diseases.
The global AAV Vector-Based Gene Therapy Drugs market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (LP Information)' newest research report, the “AAV Vector-Based Gene Therapy Drugs Industry Forecast” looks at past sales and reviews total world AAV Vector-Based Gene Therapy Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected AAV Vector-Based Gene Therapy Drugs sales for 2023 through 2029. With AAV Vector-Based Gene Therapy Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world AAV Vector-Based Gene Therapy Drugs industry.
This Insight Report provides a comprehensive analysis of the global AAV Vector-Based Gene Therapy Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on AAV Vector-Based Gene Therapy Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global AAV Vector-Based Gene Therapy Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for AAV Vector-Based Gene Therapy Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global AAV Vector-Based Gene Therapy Drugs.
United States market for AAV Vector-Based Gene Therapy Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for AAV Vector-Based Gene Therapy Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for AAV Vector-Based Gene Therapy Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key AAV Vector-Based Gene Therapy Drugs players cover uniQure, Spark Therapeutics, AveXis (Novartis), PTC Therapeutics, BioMarin, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of AAV Vector-Based Gene Therapy Drugs market by product type, application, key players and key regions and countries.
Segmentation by Type:
- AAV2 Vector
- AAV5 Vector
- Others
- Hospital
- Diagnostic and Testing Laboratories
- Academic and Research Organizations
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AAV2 Vector
- AAV5 Vector
- Others
- Hospital
- Diagnostic and Testing Laboratories
- Academic and Research Organizations
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- uniQure
- Spark Therapeutics
- AveXis (Novartis)
- PTC Therapeutics
- BioMarin
- Sarepta Therapeutics
- Roche
- Pfizer
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global AAV Vector-Based Gene Therapy Drugs Market Size 2019-2030
2.1.2 AAV Vector-Based Gene Therapy Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for AAV Vector-Based Gene Therapy Drugs by Country/Region, 2019, 2023 & 2030
2.2 AAV Vector-Based Gene Therapy Drugs Segment by Type
2.2.1 AAV2 Vector
2.2.2 AAV5 Vector
2.2.3 Others
2.3 AAV Vector-Based Gene Therapy Drugs Market Size by Type
2.3.1 AAV Vector-Based Gene Therapy Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global AAV Vector-Based Gene Therapy Drugs Market Size Market Share by Type (2019-2024)
2.4 AAV Vector-Based Gene Therapy Drugs Segment by Application
2.4.1 Hospital
2.4.2 Diagnostic and Testing Laboratories
2.4.3 Academic and Research Organizations
2.4.4 Others
2.5 AAV Vector-Based Gene Therapy Drugs Market Size by Application
2.5.1 AAV Vector-Based Gene Therapy Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global AAV Vector-Based Gene Therapy Drugs Market Size Market Share by Application (2019-2024)
3 AAV VECTOR-BASED GENE THERAPY DRUGS MARKET SIZE BY PLAYER
3.1 AAV Vector-Based Gene Therapy Drugs Market Size Market Share by Player
3.1.1 Global AAV Vector-Based Gene Therapy Drugs Revenue by Player (2019-2024)
3.1.2 Global AAV Vector-Based Gene Therapy Drugs Revenue Market Share by Player (2019-2024)
3.2 Global AAV Vector-Based Gene Therapy Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 AAV VECTOR-BASED GENE THERAPY DRUGS BY REGION
4.1 AAV Vector-Based Gene Therapy Drugs Market Size by Region (2019-2024)
4.2 Global AAV Vector-Based Gene Therapy Drugs Annual Revenue by Country/Region (2019-2024)
4.3 Americas AAV Vector-Based Gene Therapy Drugs Market Size Growth (2019-2024)
4.4 APAC AAV Vector-Based Gene Therapy Drugs Market Size Growth (2019-2024)
4.5 Europe AAV Vector-Based Gene Therapy Drugs Market Size Growth (2019-2024)
4.6 Middle East & Africa AAV Vector-Based Gene Therapy Drugs Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas AAV Vector-Based Gene Therapy Drugs Market Size by Country (2019-2024)
5.2 Americas AAV Vector-Based Gene Therapy Drugs Market Size by Type (2019-2024)
5.3 Americas AAV Vector-Based Gene Therapy Drugs Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC AAV Vector-Based Gene Therapy Drugs Market Size by Region (2019-2024)
6.2 APAC AAV Vector-Based Gene Therapy Drugs Market Size by Type (2019-2024)
6.3 APAC AAV Vector-Based Gene Therapy Drugs Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe AAV Vector-Based Gene Therapy Drugs Market Size by Country (2019-2024)
7.2 Europe AAV Vector-Based Gene Therapy Drugs Market Size by Type (2019-2024)
7.3 Europe AAV Vector-Based Gene Therapy Drugs Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa AAV Vector-Based Gene Therapy Drugs by Region (2019-2024)
8.2 Middle East & Africa AAV Vector-Based Gene Therapy Drugs Market Size by Type (2019-2024)
8.3 Middle East & Africa AAV Vector-Based Gene Therapy Drugs Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL AAV VECTOR-BASED GENE THERAPY DRUGS MARKET FORECAST
10.1 Global AAV Vector-Based Gene Therapy Drugs Forecast by Region (2025-2030)
10.1.1 Global AAV Vector-Based Gene Therapy Drugs Forecast by Region (2025-2030)
10.1.2 Americas AAV Vector-Based Gene Therapy Drugs Forecast
10.1.3 APAC AAV Vector-Based Gene Therapy Drugs Forecast
10.1.4 Europe AAV Vector-Based Gene Therapy Drugs Forecast
10.1.5 Middle East & Africa AAV Vector-Based Gene Therapy Drugs Forecast
10.2 Americas AAV Vector-Based Gene Therapy Drugs Forecast by Country (2025-2030)
10.2.1 United States Market AAV Vector-Based Gene Therapy Drugs Forecast
10.2.2 Canada Market AAV Vector-Based Gene Therapy Drugs Forecast
10.2.3 Mexico Market AAV Vector-Based Gene Therapy Drugs Forecast
10.2.4 Brazil Market AAV Vector-Based Gene Therapy Drugs Forecast
10.3 APAC AAV Vector-Based Gene Therapy Drugs Forecast by Region (2025-2030)
10.3.1 China AAV Vector-Based Gene Therapy Drugs Market Forecast
10.3.2 Japan Market AAV Vector-Based Gene Therapy Drugs Forecast
10.3.3 Korea Market AAV Vector-Based Gene Therapy Drugs Forecast
10.3.4 Southeast Asia Market AAV Vector-Based Gene Therapy Drugs Forecast
10.3.5 India Market AAV Vector-Based Gene Therapy Drugs Forecast
10.3.6 Australia Market AAV Vector-Based Gene Therapy Drugs Forecast
10.4 Europe AAV Vector-Based Gene Therapy Drugs Forecast by Country (2025-2030)
10.4.1 Germany Market AAV Vector-Based Gene Therapy Drugs Forecast
10.4.2 France Market AAV Vector-Based Gene Therapy Drugs Forecast
10.4.3 UK Market AAV Vector-Based Gene Therapy Drugs Forecast
10.4.4 Italy Market AAV Vector-Based Gene Therapy Drugs Forecast
10.4.5 Russia Market AAV Vector-Based Gene Therapy Drugs Forecast
10.5 Middle East & Africa AAV Vector-Based Gene Therapy Drugs Forecast by Region (2025-2030)
10.5.1 Egypt Market AAV Vector-Based Gene Therapy Drugs Forecast
10.5.2 South Africa Market AAV Vector-Based Gene Therapy Drugs Forecast
10.5.3 Israel Market AAV Vector-Based Gene Therapy Drugs Forecast
10.5.4 Turkey Market AAV Vector-Based Gene Therapy Drugs Forecast
10.6 Global AAV Vector-Based Gene Therapy Drugs Forecast by Type (2025-2030)
10.7 Global AAV Vector-Based Gene Therapy Drugs Forecast by Application (2025-2030)
10.7.1 GCC Countries Market AAV Vector-Based Gene Therapy Drugs Forecast
11 KEY PLAYERS ANALYSIS
11.1 uniQure
11.1.1 uniQure Company Information
11.1.2 uniQure AAV Vector-Based Gene Therapy Drugs Product Offered
11.1.3 uniQure AAV Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 uniQure Main Business Overview
11.1.5 uniQure Latest Developments
11.2 Spark Therapeutics
11.2.1 Spark Therapeutics Company Information
11.2.2 Spark Therapeutics AAV Vector-Based Gene Therapy Drugs Product Offered
11.2.3 Spark Therapeutics AAV Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Spark Therapeutics Main Business Overview
11.2.5 Spark Therapeutics Latest Developments
11.3 AveXis (Novartis)
11.3.1 AveXis (Novartis) Company Information
11.3.2 AveXis (Novartis) AAV Vector-Based Gene Therapy Drugs Product Offered
11.3.3 AveXis (Novartis) AAV Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 AveXis (Novartis) Main Business Overview
11.3.5 AveXis (Novartis) Latest Developments
11.4 PTC Therapeutics
11.4.1 PTC Therapeutics Company Information
11.4.2 PTC Therapeutics AAV Vector-Based Gene Therapy Drugs Product Offered
11.4.3 PTC Therapeutics AAV Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 PTC Therapeutics Main Business Overview
11.4.5 PTC Therapeutics Latest Developments
11.5 BioMarin
11.5.1 BioMarin Company Information
11.5.2 BioMarin AAV Vector-Based Gene Therapy Drugs Product Offered
11.5.3 BioMarin AAV Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 BioMarin Main Business Overview
11.5.5 BioMarin Latest Developments
11.6 Sarepta Therapeutics
11.6.1 Sarepta Therapeutics Company Information
11.6.2 Sarepta Therapeutics AAV Vector-Based Gene Therapy Drugs Product Offered
11.6.3 Sarepta Therapeutics AAV Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Sarepta Therapeutics Main Business Overview
11.6.5 Sarepta Therapeutics Latest Developments
11.7 Roche
11.7.1 Roche Company Information
11.7.2 Roche AAV Vector-Based Gene Therapy Drugs Product Offered
11.7.3 Roche AAV Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Roche Main Business Overview
11.7.5 Roche Latest Developments
11.8 Pfizer
11.8.1 Pfizer Company Information
11.8.2 Pfizer AAV Vector-Based Gene Therapy Drugs Product Offered
11.8.3 Pfizer AAV Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Pfizer Main Business Overview
11.8.5 Pfizer Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global AAV Vector-Based Gene Therapy Drugs Market Size 2019-2030
2.1.2 AAV Vector-Based Gene Therapy Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for AAV Vector-Based Gene Therapy Drugs by Country/Region, 2019, 2023 & 2030
2.2 AAV Vector-Based Gene Therapy Drugs Segment by Type
2.2.1 AAV2 Vector
2.2.2 AAV5 Vector
2.2.3 Others
2.3 AAV Vector-Based Gene Therapy Drugs Market Size by Type
2.3.1 AAV Vector-Based Gene Therapy Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global AAV Vector-Based Gene Therapy Drugs Market Size Market Share by Type (2019-2024)
2.4 AAV Vector-Based Gene Therapy Drugs Segment by Application
2.4.1 Hospital
2.4.2 Diagnostic and Testing Laboratories
2.4.3 Academic and Research Organizations
2.4.4 Others
2.5 AAV Vector-Based Gene Therapy Drugs Market Size by Application
2.5.1 AAV Vector-Based Gene Therapy Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global AAV Vector-Based Gene Therapy Drugs Market Size Market Share by Application (2019-2024)
3 AAV VECTOR-BASED GENE THERAPY DRUGS MARKET SIZE BY PLAYER
3.1 AAV Vector-Based Gene Therapy Drugs Market Size Market Share by Player
3.1.1 Global AAV Vector-Based Gene Therapy Drugs Revenue by Player (2019-2024)
3.1.2 Global AAV Vector-Based Gene Therapy Drugs Revenue Market Share by Player (2019-2024)
3.2 Global AAV Vector-Based Gene Therapy Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 AAV VECTOR-BASED GENE THERAPY DRUGS BY REGION
4.1 AAV Vector-Based Gene Therapy Drugs Market Size by Region (2019-2024)
4.2 Global AAV Vector-Based Gene Therapy Drugs Annual Revenue by Country/Region (2019-2024)
4.3 Americas AAV Vector-Based Gene Therapy Drugs Market Size Growth (2019-2024)
4.4 APAC AAV Vector-Based Gene Therapy Drugs Market Size Growth (2019-2024)
4.5 Europe AAV Vector-Based Gene Therapy Drugs Market Size Growth (2019-2024)
4.6 Middle East & Africa AAV Vector-Based Gene Therapy Drugs Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas AAV Vector-Based Gene Therapy Drugs Market Size by Country (2019-2024)
5.2 Americas AAV Vector-Based Gene Therapy Drugs Market Size by Type (2019-2024)
5.3 Americas AAV Vector-Based Gene Therapy Drugs Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC AAV Vector-Based Gene Therapy Drugs Market Size by Region (2019-2024)
6.2 APAC AAV Vector-Based Gene Therapy Drugs Market Size by Type (2019-2024)
6.3 APAC AAV Vector-Based Gene Therapy Drugs Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe AAV Vector-Based Gene Therapy Drugs Market Size by Country (2019-2024)
7.2 Europe AAV Vector-Based Gene Therapy Drugs Market Size by Type (2019-2024)
7.3 Europe AAV Vector-Based Gene Therapy Drugs Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa AAV Vector-Based Gene Therapy Drugs by Region (2019-2024)
8.2 Middle East & Africa AAV Vector-Based Gene Therapy Drugs Market Size by Type (2019-2024)
8.3 Middle East & Africa AAV Vector-Based Gene Therapy Drugs Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL AAV VECTOR-BASED GENE THERAPY DRUGS MARKET FORECAST
10.1 Global AAV Vector-Based Gene Therapy Drugs Forecast by Region (2025-2030)
10.1.1 Global AAV Vector-Based Gene Therapy Drugs Forecast by Region (2025-2030)
10.1.2 Americas AAV Vector-Based Gene Therapy Drugs Forecast
10.1.3 APAC AAV Vector-Based Gene Therapy Drugs Forecast
10.1.4 Europe AAV Vector-Based Gene Therapy Drugs Forecast
10.1.5 Middle East & Africa AAV Vector-Based Gene Therapy Drugs Forecast
10.2 Americas AAV Vector-Based Gene Therapy Drugs Forecast by Country (2025-2030)
10.2.1 United States Market AAV Vector-Based Gene Therapy Drugs Forecast
10.2.2 Canada Market AAV Vector-Based Gene Therapy Drugs Forecast
10.2.3 Mexico Market AAV Vector-Based Gene Therapy Drugs Forecast
10.2.4 Brazil Market AAV Vector-Based Gene Therapy Drugs Forecast
10.3 APAC AAV Vector-Based Gene Therapy Drugs Forecast by Region (2025-2030)
10.3.1 China AAV Vector-Based Gene Therapy Drugs Market Forecast
10.3.2 Japan Market AAV Vector-Based Gene Therapy Drugs Forecast
10.3.3 Korea Market AAV Vector-Based Gene Therapy Drugs Forecast
10.3.4 Southeast Asia Market AAV Vector-Based Gene Therapy Drugs Forecast
10.3.5 India Market AAV Vector-Based Gene Therapy Drugs Forecast
10.3.6 Australia Market AAV Vector-Based Gene Therapy Drugs Forecast
10.4 Europe AAV Vector-Based Gene Therapy Drugs Forecast by Country (2025-2030)
10.4.1 Germany Market AAV Vector-Based Gene Therapy Drugs Forecast
10.4.2 France Market AAV Vector-Based Gene Therapy Drugs Forecast
10.4.3 UK Market AAV Vector-Based Gene Therapy Drugs Forecast
10.4.4 Italy Market AAV Vector-Based Gene Therapy Drugs Forecast
10.4.5 Russia Market AAV Vector-Based Gene Therapy Drugs Forecast
10.5 Middle East & Africa AAV Vector-Based Gene Therapy Drugs Forecast by Region (2025-2030)
10.5.1 Egypt Market AAV Vector-Based Gene Therapy Drugs Forecast
10.5.2 South Africa Market AAV Vector-Based Gene Therapy Drugs Forecast
10.5.3 Israel Market AAV Vector-Based Gene Therapy Drugs Forecast
10.5.4 Turkey Market AAV Vector-Based Gene Therapy Drugs Forecast
10.6 Global AAV Vector-Based Gene Therapy Drugs Forecast by Type (2025-2030)
10.7 Global AAV Vector-Based Gene Therapy Drugs Forecast by Application (2025-2030)
10.7.1 GCC Countries Market AAV Vector-Based Gene Therapy Drugs Forecast
11 KEY PLAYERS ANALYSIS
11.1 uniQure
11.1.1 uniQure Company Information
11.1.2 uniQure AAV Vector-Based Gene Therapy Drugs Product Offered
11.1.3 uniQure AAV Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 uniQure Main Business Overview
11.1.5 uniQure Latest Developments
11.2 Spark Therapeutics
11.2.1 Spark Therapeutics Company Information
11.2.2 Spark Therapeutics AAV Vector-Based Gene Therapy Drugs Product Offered
11.2.3 Spark Therapeutics AAV Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Spark Therapeutics Main Business Overview
11.2.5 Spark Therapeutics Latest Developments
11.3 AveXis (Novartis)
11.3.1 AveXis (Novartis) Company Information
11.3.2 AveXis (Novartis) AAV Vector-Based Gene Therapy Drugs Product Offered
11.3.3 AveXis (Novartis) AAV Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 AveXis (Novartis) Main Business Overview
11.3.5 AveXis (Novartis) Latest Developments
11.4 PTC Therapeutics
11.4.1 PTC Therapeutics Company Information
11.4.2 PTC Therapeutics AAV Vector-Based Gene Therapy Drugs Product Offered
11.4.3 PTC Therapeutics AAV Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 PTC Therapeutics Main Business Overview
11.4.5 PTC Therapeutics Latest Developments
11.5 BioMarin
11.5.1 BioMarin Company Information
11.5.2 BioMarin AAV Vector-Based Gene Therapy Drugs Product Offered
11.5.3 BioMarin AAV Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 BioMarin Main Business Overview
11.5.5 BioMarin Latest Developments
11.6 Sarepta Therapeutics
11.6.1 Sarepta Therapeutics Company Information
11.6.2 Sarepta Therapeutics AAV Vector-Based Gene Therapy Drugs Product Offered
11.6.3 Sarepta Therapeutics AAV Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Sarepta Therapeutics Main Business Overview
11.6.5 Sarepta Therapeutics Latest Developments
11.7 Roche
11.7.1 Roche Company Information
11.7.2 Roche AAV Vector-Based Gene Therapy Drugs Product Offered
11.7.3 Roche AAV Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Roche Main Business Overview
11.7.5 Roche Latest Developments
11.8 Pfizer
11.8.1 Pfizer Company Information
11.8.2 Pfizer AAV Vector-Based Gene Therapy Drugs Product Offered
11.8.3 Pfizer AAV Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Pfizer Main Business Overview
11.8.5 Pfizer Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. AAV Vector-Based Gene Therapy Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. AAV Vector-Based Gene Therapy Drugs Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of AAV2 Vector
Table 4. Major Players of AAV5 Vector
Table 5. Major Players of Others
Table 6. AAV Vector-Based Gene Therapy Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 7. Global AAV Vector-Based Gene Therapy Drugs Market Size by Type (2019-2024) & ($ millions)
Table 8. Global AAV Vector-Based Gene Therapy Drugs Market Size Market Share by Type (2019-2024)
Table 9. AAV Vector-Based Gene Therapy Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 10. Global AAV Vector-Based Gene Therapy Drugs Market Size by Application (2019-2024) & ($ millions)
Table 11. Global AAV Vector-Based Gene Therapy Drugs Market Size Market Share by Application (2019-2024)
Table 12. Global AAV Vector-Based Gene Therapy Drugs Revenue by Player (2019-2024) & ($ millions)
Table 13. Global AAV Vector-Based Gene Therapy Drugs Revenue Market Share by Player (2019-2024)
Table 14. AAV Vector-Based Gene Therapy Drugs Key Players Head office and Products Offered
Table 15. AAV Vector-Based Gene Therapy Drugs Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global AAV Vector-Based Gene Therapy Drugs Market Size by Region (2019-2024) & ($ millions)
Table 19. Global AAV Vector-Based Gene Therapy Drugs Market Size Market Share by Region (2019-2024)
Table 20. Global AAV Vector-Based Gene Therapy Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global AAV Vector-Based Gene Therapy Drugs Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas AAV Vector-Based Gene Therapy Drugs Market Size by Country (2019-2024) & ($ millions)
Table 23. Americas AAV Vector-Based Gene Therapy Drugs Market Size Market Share by Country (2019-2024)
Table 24. Americas AAV Vector-Based Gene Therapy Drugs Market Size by Type (2019-2024) & ($ millions)
Table 25. Americas AAV Vector-Based Gene Therapy Drugs Market Size Market Share by Type (2019-2024)
Table 26. Americas AAV Vector-Based Gene Therapy Drugs Market Size by Application (2019-2024) & ($ millions)
Table 27. Americas AAV Vector-Based Gene Therapy Drugs Market Size Market Share by Application (2019-2024)
Table 28. APAC AAV Vector-Based Gene Therapy Drugs Market Size by Region (2019-2024) & ($ millions)
Table 29. APAC AAV Vector-Based Gene Therapy Drugs Market Size Market Share by Region (2019-2024)
Table 30. APAC AAV Vector-Based Gene Therapy Drugs Market Size by Type (2019-2024) & ($ millions)
Table 31. APAC AAV Vector-Based Gene Therapy Drugs Market Size by Application (2019-2024) & ($ millions)
Table 32. Europe AAV Vector-Based Gene Therapy Drugs Market Size by Country (2019-2024) & ($ millions)
Table 33. Europe AAV Vector-Based Gene Therapy Drugs Market Size Market Share by Country (2019-2024)
Table 34. Europe AAV Vector-Based Gene Therapy Drugs Market Size by Type (2019-2024) & ($ millions)
Table 35. Europe AAV Vector-Based Gene Therapy Drugs Market Size by Application (2019-2024) & ($ millions)
Table 36. Middle East & Africa AAV Vector-Based Gene Therapy Drugs Market Size by Region (2019-2024) & ($ millions)
Table 37. Middle East & Africa AAV Vector-Based Gene Therapy Drugs Market Size by Type (2019-2024) & ($ millions)
Table 38. Middle East & Africa AAV Vector-Based Gene Therapy Drugs Market Size by Application (2019-2024) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of AAV Vector-Based Gene Therapy Drugs
Table 40. Key Market Challenges & Risks of AAV Vector-Based Gene Therapy Drugs
Table 41. Key Industry Trends of AAV Vector-Based Gene Therapy Drugs
Table 42. Global AAV Vector-Based Gene Therapy Drugs Market Size Forecast by Region (2025-2030) & ($ millions)
Table 43. Global AAV Vector-Based Gene Therapy Drugs Market Size Market Share Forecast by Region (2025-2030)
Table 44. Global AAV Vector-Based Gene Therapy Drugs Market Size Forecast by Type (2025-2030) & ($ millions)
Table 45. Global AAV Vector-Based Gene Therapy Drugs Market Size Forecast by Application (2025-2030) & ($ millions)
Table 46. uniQure Details, Company Type, AAV Vector-Based Gene Therapy Drugs Area Served and Its Competitors
Table 47. uniQure AAV Vector-Based Gene Therapy Drugs Product Offered
Table 48. uniQure AAV Vector-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 49. uniQure Main Business
Table 50. uniQure Latest Developments
Table 51. Spark Therapeutics Details, Company Type, AAV Vector-Based Gene Therapy Drugs Area Served and Its Competitors
Table 52. Spark Therapeutics AAV Vector-Based Gene Therapy Drugs Product Offered
Table 53. Spark Therapeutics AAV Vector-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Spark Therapeutics Main Business
Table 55. Spark Therapeutics Latest Developments
Table 56. AveXis (Novartis) Details, Company Type, AAV Vector-Based Gene Therapy Drugs Area Served and Its Competitors
Table 57. AveXis (Novartis) AAV Vector-Based Gene Therapy Drugs Product Offered
Table 58. AveXis (Novartis) AAV Vector-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 59. AveXis (Novartis) Main Business
Table 60. AveXis (Novartis) Latest Developments
Table 61. PTC Therapeutics Details, Company Type, AAV Vector-Based Gene Therapy Drugs Area Served and Its Competitors
Table 62. PTC Therapeutics AAV Vector-Based Gene Therapy Drugs Product Offered
Table 63. PTC Therapeutics AAV Vector-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 64. PTC Therapeutics Main Business
Table 65. PTC Therapeutics Latest Developments
Table 66. BioMarin Details, Company Type, AAV Vector-Based Gene Therapy Drugs Area Served and Its Competitors
Table 67. BioMarin AAV Vector-Based Gene Therapy Drugs Product Offered
Table 68. BioMarin AAV Vector-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 69. BioMarin Main Business
Table 70. BioMarin Latest Developments
Table 71. Sarepta Therapeutics Details, Company Type, AAV Vector-Based Gene Therapy Drugs Area Served and Its Competitors
Table 72. Sarepta Therapeutics AAV Vector-Based Gene Therapy Drugs Product Offered
Table 73. Sarepta Therapeutics AAV Vector-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 74. Sarepta Therapeutics Main Business
Table 75. Sarepta Therapeutics Latest Developments
Table 76. Roche Details, Company Type, AAV Vector-Based Gene Therapy Drugs Area Served and Its Competitors
Table 77. Roche AAV Vector-Based Gene Therapy Drugs Product Offered
Table 78. Roche AAV Vector-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 79. Roche Main Business
Table 80. Roche Latest Developments
Table 81. Pfizer Details, Company Type, AAV Vector-Based Gene Therapy Drugs Area Served and Its Competitors
Table 82. Pfizer AAV Vector-Based Gene Therapy Drugs Product Offered
Table 83. Pfizer AAV Vector-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 84. Pfizer Main Business
Table 85. Pfizer Latest Developments
Table 1. AAV Vector-Based Gene Therapy Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. AAV Vector-Based Gene Therapy Drugs Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of AAV2 Vector
Table 4. Major Players of AAV5 Vector
Table 5. Major Players of Others
Table 6. AAV Vector-Based Gene Therapy Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 7. Global AAV Vector-Based Gene Therapy Drugs Market Size by Type (2019-2024) & ($ millions)
Table 8. Global AAV Vector-Based Gene Therapy Drugs Market Size Market Share by Type (2019-2024)
Table 9. AAV Vector-Based Gene Therapy Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 10. Global AAV Vector-Based Gene Therapy Drugs Market Size by Application (2019-2024) & ($ millions)
Table 11. Global AAV Vector-Based Gene Therapy Drugs Market Size Market Share by Application (2019-2024)
Table 12. Global AAV Vector-Based Gene Therapy Drugs Revenue by Player (2019-2024) & ($ millions)
Table 13. Global AAV Vector-Based Gene Therapy Drugs Revenue Market Share by Player (2019-2024)
Table 14. AAV Vector-Based Gene Therapy Drugs Key Players Head office and Products Offered
Table 15. AAV Vector-Based Gene Therapy Drugs Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global AAV Vector-Based Gene Therapy Drugs Market Size by Region (2019-2024) & ($ millions)
Table 19. Global AAV Vector-Based Gene Therapy Drugs Market Size Market Share by Region (2019-2024)
Table 20. Global AAV Vector-Based Gene Therapy Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global AAV Vector-Based Gene Therapy Drugs Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas AAV Vector-Based Gene Therapy Drugs Market Size by Country (2019-2024) & ($ millions)
Table 23. Americas AAV Vector-Based Gene Therapy Drugs Market Size Market Share by Country (2019-2024)
Table 24. Americas AAV Vector-Based Gene Therapy Drugs Market Size by Type (2019-2024) & ($ millions)
Table 25. Americas AAV Vector-Based Gene Therapy Drugs Market Size Market Share by Type (2019-2024)
Table 26. Americas AAV Vector-Based Gene Therapy Drugs Market Size by Application (2019-2024) & ($ millions)
Table 27. Americas AAV Vector-Based Gene Therapy Drugs Market Size Market Share by Application (2019-2024)
Table 28. APAC AAV Vector-Based Gene Therapy Drugs Market Size by Region (2019-2024) & ($ millions)
Table 29. APAC AAV Vector-Based Gene Therapy Drugs Market Size Market Share by Region (2019-2024)
Table 30. APAC AAV Vector-Based Gene Therapy Drugs Market Size by Type (2019-2024) & ($ millions)
Table 31. APAC AAV Vector-Based Gene Therapy Drugs Market Size by Application (2019-2024) & ($ millions)
Table 32. Europe AAV Vector-Based Gene Therapy Drugs Market Size by Country (2019-2024) & ($ millions)
Table 33. Europe AAV Vector-Based Gene Therapy Drugs Market Size Market Share by Country (2019-2024)
Table 34. Europe AAV Vector-Based Gene Therapy Drugs Market Size by Type (2019-2024) & ($ millions)
Table 35. Europe AAV Vector-Based Gene Therapy Drugs Market Size by Application (2019-2024) & ($ millions)
Table 36. Middle East & Africa AAV Vector-Based Gene Therapy Drugs Market Size by Region (2019-2024) & ($ millions)
Table 37. Middle East & Africa AAV Vector-Based Gene Therapy Drugs Market Size by Type (2019-2024) & ($ millions)
Table 38. Middle East & Africa AAV Vector-Based Gene Therapy Drugs Market Size by Application (2019-2024) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of AAV Vector-Based Gene Therapy Drugs
Table 40. Key Market Challenges & Risks of AAV Vector-Based Gene Therapy Drugs
Table 41. Key Industry Trends of AAV Vector-Based Gene Therapy Drugs
Table 42. Global AAV Vector-Based Gene Therapy Drugs Market Size Forecast by Region (2025-2030) & ($ millions)
Table 43. Global AAV Vector-Based Gene Therapy Drugs Market Size Market Share Forecast by Region (2025-2030)
Table 44. Global AAV Vector-Based Gene Therapy Drugs Market Size Forecast by Type (2025-2030) & ($ millions)
Table 45. Global AAV Vector-Based Gene Therapy Drugs Market Size Forecast by Application (2025-2030) & ($ millions)
Table 46. uniQure Details, Company Type, AAV Vector-Based Gene Therapy Drugs Area Served and Its Competitors
Table 47. uniQure AAV Vector-Based Gene Therapy Drugs Product Offered
Table 48. uniQure AAV Vector-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 49. uniQure Main Business
Table 50. uniQure Latest Developments
Table 51. Spark Therapeutics Details, Company Type, AAV Vector-Based Gene Therapy Drugs Area Served and Its Competitors
Table 52. Spark Therapeutics AAV Vector-Based Gene Therapy Drugs Product Offered
Table 53. Spark Therapeutics AAV Vector-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Spark Therapeutics Main Business
Table 55. Spark Therapeutics Latest Developments
Table 56. AveXis (Novartis) Details, Company Type, AAV Vector-Based Gene Therapy Drugs Area Served and Its Competitors
Table 57. AveXis (Novartis) AAV Vector-Based Gene Therapy Drugs Product Offered
Table 58. AveXis (Novartis) AAV Vector-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 59. AveXis (Novartis) Main Business
Table 60. AveXis (Novartis) Latest Developments
Table 61. PTC Therapeutics Details, Company Type, AAV Vector-Based Gene Therapy Drugs Area Served and Its Competitors
Table 62. PTC Therapeutics AAV Vector-Based Gene Therapy Drugs Product Offered
Table 63. PTC Therapeutics AAV Vector-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 64. PTC Therapeutics Main Business
Table 65. PTC Therapeutics Latest Developments
Table 66. BioMarin Details, Company Type, AAV Vector-Based Gene Therapy Drugs Area Served and Its Competitors
Table 67. BioMarin AAV Vector-Based Gene Therapy Drugs Product Offered
Table 68. BioMarin AAV Vector-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 69. BioMarin Main Business
Table 70. BioMarin Latest Developments
Table 71. Sarepta Therapeutics Details, Company Type, AAV Vector-Based Gene Therapy Drugs Area Served and Its Competitors
Table 72. Sarepta Therapeutics AAV Vector-Based Gene Therapy Drugs Product Offered
Table 73. Sarepta Therapeutics AAV Vector-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 74. Sarepta Therapeutics Main Business
Table 75. Sarepta Therapeutics Latest Developments
Table 76. Roche Details, Company Type, AAV Vector-Based Gene Therapy Drugs Area Served and Its Competitors
Table 77. Roche AAV Vector-Based Gene Therapy Drugs Product Offered
Table 78. Roche AAV Vector-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 79. Roche Main Business
Table 80. Roche Latest Developments
Table 81. Pfizer Details, Company Type, AAV Vector-Based Gene Therapy Drugs Area Served and Its Competitors
Table 82. Pfizer AAV Vector-Based Gene Therapy Drugs Product Offered
Table 83. Pfizer AAV Vector-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 84. Pfizer Main Business
Table 85. Pfizer Latest Developments
LIST OF FIGURES
Figure 1. AAV Vector-Based Gene Therapy Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global AAV Vector-Based Gene Therapy Drugs Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. AAV Vector-Based Gene Therapy Drugs Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. AAV Vector-Based Gene Therapy Drugs Sales Market Share by Country/Region (2023)
Figure 8. AAV Vector-Based Gene Therapy Drugs Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global AAV Vector-Based Gene Therapy Drugs Market Size Market Share by Type in 2023
Figure 10. AAV Vector-Based Gene Therapy Drugs in Hospital
Figure 11. Global AAV Vector-Based Gene Therapy Drugs Market: Hospital (2019-2024) & ($ millions)
Figure 12. AAV Vector-Based Gene Therapy Drugs in Diagnostic and Testing Laboratories
Figure 13. Global AAV Vector-Based Gene Therapy Drugs Market: Diagnostic and Testing Laboratories (2019-2024) & ($ millions)
Figure 14. AAV Vector-Based Gene Therapy Drugs in Academic and Research Organizations
Figure 15. Global AAV Vector-Based Gene Therapy Drugs Market: Academic and Research Organizations (2019-2024) & ($ millions)
Figure 16. AAV Vector-Based Gene Therapy Drugs in Others
Figure 17. Global AAV Vector-Based Gene Therapy Drugs Market: Others (2019-2024) & ($ millions)
Figure 18. Global AAV Vector-Based Gene Therapy Drugs Market Size Market Share by Application in 2023
Figure 19. Global AAV Vector-Based Gene Therapy Drugs Revenue Market Share by Player in 2023
Figure 20. Global AAV Vector-Based Gene Therapy Drugs Market Size Market Share by Region (2019-2024)
Figure 21. Americas AAV Vector-Based Gene Therapy Drugs Market Size 2019-2024 ($ millions)
Figure 22. APAC AAV Vector-Based Gene Therapy Drugs Market Size 2019-2024 ($ millions)
Figure 23. Europe AAV Vector-Based Gene Therapy Drugs Market Size 2019-2024 ($ millions)
Figure 24. Middle East & Africa AAV Vector-Based Gene Therapy Drugs Market Size 2019-2024 ($ millions)
Figure 25. Americas AAV Vector-Based Gene Therapy Drugs Value Market Share by Country in 2023
Figure 26. United States AAV Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 27. Canada AAV Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 28. Mexico AAV Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 29. Brazil AAV Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 30. APAC AAV Vector-Based Gene Therapy Drugs Market Size Market Share by Region in 2023
Figure 31. APAC AAV Vector-Based Gene Therapy Drugs Market Size Market Share by Type (2019-2024)
Figure 32. APAC AAV Vector-Based Gene Therapy Drugs Market Size Market Share by Application (2019-2024)
Figure 33. China AAV Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 34. Japan AAV Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 35. South Korea AAV Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 36. Southeast Asia AAV Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 37. India AAV Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 38. Australia AAV Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 39. Europe AAV Vector-Based Gene Therapy Drugs Market Size Market Share by Country in 2023
Figure 40. Europe AAV Vector-Based Gene Therapy Drugs Market Size Market Share by Type (2019-2024)
Figure 41. Europe AAV Vector-Based Gene Therapy Drugs Market Size Market Share by Application (2019-2024)
Figure 42. Germany AAV Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 43. France AAV Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 44. UK AAV Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 45. Italy AAV Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 46. Russia AAV Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 47. Middle East & Africa AAV Vector-Based Gene Therapy Drugs Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa AAV Vector-Based Gene Therapy Drugs Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa AAV Vector-Based Gene Therapy Drugs Market Size Market Share by Application (2019-2024)
Figure 50. Egypt AAV Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 51. South Africa AAV Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 52. Israel AAV Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 53. Turkey AAV Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 54. GCC Countries AAV Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 55. Americas AAV Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 56. APAC AAV Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 57. Europe AAV Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 58. Middle East & Africa AAV Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 59. United States AAV Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 60. Canada AAV Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 61. Mexico AAV Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 62. Brazil AAV Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 63. China AAV Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 64. Japan AAV Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 65. Korea AAV Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 66. Southeast Asia AAV Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 67. India AAV Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 68. Australia AAV Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 69. Germany AAV Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 70. France AAV Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 71. UK AAV Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 72. Italy AAV Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 73. Russia AAV Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 74. Egypt AAV Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 75. South Africa AAV Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 76. Israel AAV Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 77. Turkey AAV Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 78. GCC Countries AAV Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 79. Global AAV Vector-Based Gene Therapy Drugs Market Size Market Share Forecast by Type (2025-2030)
Figure 80. Global AAV Vector-Based Gene Therapy Drugs Market Size Market Share Forecast by Application (2025-2030)
Figure 1. AAV Vector-Based Gene Therapy Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global AAV Vector-Based Gene Therapy Drugs Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. AAV Vector-Based Gene Therapy Drugs Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. AAV Vector-Based Gene Therapy Drugs Sales Market Share by Country/Region (2023)
Figure 8. AAV Vector-Based Gene Therapy Drugs Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global AAV Vector-Based Gene Therapy Drugs Market Size Market Share by Type in 2023
Figure 10. AAV Vector-Based Gene Therapy Drugs in Hospital
Figure 11. Global AAV Vector-Based Gene Therapy Drugs Market: Hospital (2019-2024) & ($ millions)
Figure 12. AAV Vector-Based Gene Therapy Drugs in Diagnostic and Testing Laboratories
Figure 13. Global AAV Vector-Based Gene Therapy Drugs Market: Diagnostic and Testing Laboratories (2019-2024) & ($ millions)
Figure 14. AAV Vector-Based Gene Therapy Drugs in Academic and Research Organizations
Figure 15. Global AAV Vector-Based Gene Therapy Drugs Market: Academic and Research Organizations (2019-2024) & ($ millions)
Figure 16. AAV Vector-Based Gene Therapy Drugs in Others
Figure 17. Global AAV Vector-Based Gene Therapy Drugs Market: Others (2019-2024) & ($ millions)
Figure 18. Global AAV Vector-Based Gene Therapy Drugs Market Size Market Share by Application in 2023
Figure 19. Global AAV Vector-Based Gene Therapy Drugs Revenue Market Share by Player in 2023
Figure 20. Global AAV Vector-Based Gene Therapy Drugs Market Size Market Share by Region (2019-2024)
Figure 21. Americas AAV Vector-Based Gene Therapy Drugs Market Size 2019-2024 ($ millions)
Figure 22. APAC AAV Vector-Based Gene Therapy Drugs Market Size 2019-2024 ($ millions)
Figure 23. Europe AAV Vector-Based Gene Therapy Drugs Market Size 2019-2024 ($ millions)
Figure 24. Middle East & Africa AAV Vector-Based Gene Therapy Drugs Market Size 2019-2024 ($ millions)
Figure 25. Americas AAV Vector-Based Gene Therapy Drugs Value Market Share by Country in 2023
Figure 26. United States AAV Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 27. Canada AAV Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 28. Mexico AAV Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 29. Brazil AAV Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 30. APAC AAV Vector-Based Gene Therapy Drugs Market Size Market Share by Region in 2023
Figure 31. APAC AAV Vector-Based Gene Therapy Drugs Market Size Market Share by Type (2019-2024)
Figure 32. APAC AAV Vector-Based Gene Therapy Drugs Market Size Market Share by Application (2019-2024)
Figure 33. China AAV Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 34. Japan AAV Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 35. South Korea AAV Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 36. Southeast Asia AAV Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 37. India AAV Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 38. Australia AAV Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 39. Europe AAV Vector-Based Gene Therapy Drugs Market Size Market Share by Country in 2023
Figure 40. Europe AAV Vector-Based Gene Therapy Drugs Market Size Market Share by Type (2019-2024)
Figure 41. Europe AAV Vector-Based Gene Therapy Drugs Market Size Market Share by Application (2019-2024)
Figure 42. Germany AAV Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 43. France AAV Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 44. UK AAV Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 45. Italy AAV Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 46. Russia AAV Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 47. Middle East & Africa AAV Vector-Based Gene Therapy Drugs Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa AAV Vector-Based Gene Therapy Drugs Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa AAV Vector-Based Gene Therapy Drugs Market Size Market Share by Application (2019-2024)
Figure 50. Egypt AAV Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 51. South Africa AAV Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 52. Israel AAV Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 53. Turkey AAV Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 54. GCC Countries AAV Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 55. Americas AAV Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 56. APAC AAV Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 57. Europe AAV Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 58. Middle East & Africa AAV Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 59. United States AAV Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 60. Canada AAV Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 61. Mexico AAV Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 62. Brazil AAV Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 63. China AAV Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 64. Japan AAV Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 65. Korea AAV Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 66. Southeast Asia AAV Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 67. India AAV Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 68. Australia AAV Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 69. Germany AAV Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 70. France AAV Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 71. UK AAV Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 72. Italy AAV Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 73. Russia AAV Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 74. Egypt AAV Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 75. South Africa AAV Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 76. Israel AAV Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 77. Turkey AAV Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 78. GCC Countries AAV Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 79. Global AAV Vector-Based Gene Therapy Drugs Market Size Market Share Forecast by Type (2025-2030)
Figure 80. Global AAV Vector-Based Gene Therapy Drugs Market Size Market Share Forecast by Application (2025-2030)
